Cargando…

Ovatodiolide Suppresses Oral Cancer Malignancy by Down-Regulating Exosomal Mir-21/STAT3/β-Catenin Cargo and Preventing Oncogenic Transformation of Normal Gingival Fibroblasts

Oral squamous cell carcinoma (OSCC) is among the most commonly diagnosed malignancies in the world. Patients with OSCC often develop treatment resistance, resulting in a poor prognosis. Mounting evidence indicates that interactions between cancerous cells and other components of the tumor microenvir...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jia-Hong, Wu, Alexander T. H., Bamodu, Oluwaseun Adebayo, Yadav, Vijesh Kumar, Chao, Tsu-Yi, Tzeng, Yew-Min, Mukhopadhyay, Debabrata, Hsiao, Michael, Lee, Jih-Chin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017298/
https://www.ncbi.nlm.nih.gov/pubmed/31878245
http://dx.doi.org/10.3390/cancers12010056
_version_ 1783497169772216320
author Chen, Jia-Hong
Wu, Alexander T. H.
Bamodu, Oluwaseun Adebayo
Yadav, Vijesh Kumar
Chao, Tsu-Yi
Tzeng, Yew-Min
Mukhopadhyay, Debabrata
Hsiao, Michael
Lee, Jih-Chin
author_facet Chen, Jia-Hong
Wu, Alexander T. H.
Bamodu, Oluwaseun Adebayo
Yadav, Vijesh Kumar
Chao, Tsu-Yi
Tzeng, Yew-Min
Mukhopadhyay, Debabrata
Hsiao, Michael
Lee, Jih-Chin
author_sort Chen, Jia-Hong
collection PubMed
description Oral squamous cell carcinoma (OSCC) is among the most commonly diagnosed malignancies in the world. Patients with OSCC often develop treatment resistance, resulting in a poor prognosis. Mounting evidence indicates that interactions between cancerous cells and other components of the tumor microenvironment (TME) determine their response to treatment. Herein, we examined the role of cancer stem cell-derived extracellular vesicles (CSC_EVs) generated from CAL27 and SCC-15 OSCC cells in the development of cisplatin (CDDP) resistance. We demonstrated that CSC_EVs enhance CDDP resistance, clonogenicity, and the tumorsphere formation potential of OSCC cells. Our bioinformatics analyses revealed that OSCC_EVs are enriched with microRNA (miR)-21-5p and are associated with increased metastasis, stemness, chemoresistance, and poor survival in patients with OSCC. Mechanistically, enhanced activity of CSC_EVs was positively correlated with upregulated β-catenin, phosphatidylinositol-3 kinase (PI3K), signal transducer and activator of transcription 3 (STAT3), mammalian target of rapamycin (mTOR), and transforming growth factor (TGF)-β1 messenger (m)RNA and protein expression levels. CSC_EVs also conferred a cancer-associated fibroblast (CAF) phenotype on normal gingival fibroblasts (NGFs), with the resultant CAFs enhancing the oncogenicity of OSCC cells. Interestingly, treatment with ovatodiolide (OV), the bioactive component of Anisomeles indica, suppressed OSCC tumorigenesis by reducing the cargo content of EVs derived from CSCs, suppressing self-renewal, and inhibiting the NGF-CAF transformation by disrupting EV-TME interactions. Moreover, by suppressing miR-21-5p, STAT3, and mTOR expressions in CSC_EVs, OV re-sensitized CSCs to CDDP and suppressed OSCC tumorigenesis. In vivo, treatment with OV alone or in combination with CDDP significantly reduced the tumor sphere-forming ability and decreased EV cargos containing mTOR, PI3K, STAT3, β-catenin, and miR-21-5p. In summary, our findings provide further strong evidence of OV’s therapeutic effect in OSCC.
format Online
Article
Text
id pubmed-7017298
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70172982020-02-28 Ovatodiolide Suppresses Oral Cancer Malignancy by Down-Regulating Exosomal Mir-21/STAT3/β-Catenin Cargo and Preventing Oncogenic Transformation of Normal Gingival Fibroblasts Chen, Jia-Hong Wu, Alexander T. H. Bamodu, Oluwaseun Adebayo Yadav, Vijesh Kumar Chao, Tsu-Yi Tzeng, Yew-Min Mukhopadhyay, Debabrata Hsiao, Michael Lee, Jih-Chin Cancers (Basel) Article Oral squamous cell carcinoma (OSCC) is among the most commonly diagnosed malignancies in the world. Patients with OSCC often develop treatment resistance, resulting in a poor prognosis. Mounting evidence indicates that interactions between cancerous cells and other components of the tumor microenvironment (TME) determine their response to treatment. Herein, we examined the role of cancer stem cell-derived extracellular vesicles (CSC_EVs) generated from CAL27 and SCC-15 OSCC cells in the development of cisplatin (CDDP) resistance. We demonstrated that CSC_EVs enhance CDDP resistance, clonogenicity, and the tumorsphere formation potential of OSCC cells. Our bioinformatics analyses revealed that OSCC_EVs are enriched with microRNA (miR)-21-5p and are associated with increased metastasis, stemness, chemoresistance, and poor survival in patients with OSCC. Mechanistically, enhanced activity of CSC_EVs was positively correlated with upregulated β-catenin, phosphatidylinositol-3 kinase (PI3K), signal transducer and activator of transcription 3 (STAT3), mammalian target of rapamycin (mTOR), and transforming growth factor (TGF)-β1 messenger (m)RNA and protein expression levels. CSC_EVs also conferred a cancer-associated fibroblast (CAF) phenotype on normal gingival fibroblasts (NGFs), with the resultant CAFs enhancing the oncogenicity of OSCC cells. Interestingly, treatment with ovatodiolide (OV), the bioactive component of Anisomeles indica, suppressed OSCC tumorigenesis by reducing the cargo content of EVs derived from CSCs, suppressing self-renewal, and inhibiting the NGF-CAF transformation by disrupting EV-TME interactions. Moreover, by suppressing miR-21-5p, STAT3, and mTOR expressions in CSC_EVs, OV re-sensitized CSCs to CDDP and suppressed OSCC tumorigenesis. In vivo, treatment with OV alone or in combination with CDDP significantly reduced the tumor sphere-forming ability and decreased EV cargos containing mTOR, PI3K, STAT3, β-catenin, and miR-21-5p. In summary, our findings provide further strong evidence of OV’s therapeutic effect in OSCC. MDPI 2019-12-24 /pmc/articles/PMC7017298/ /pubmed/31878245 http://dx.doi.org/10.3390/cancers12010056 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Chen, Jia-Hong
Wu, Alexander T. H.
Bamodu, Oluwaseun Adebayo
Yadav, Vijesh Kumar
Chao, Tsu-Yi
Tzeng, Yew-Min
Mukhopadhyay, Debabrata
Hsiao, Michael
Lee, Jih-Chin
Ovatodiolide Suppresses Oral Cancer Malignancy by Down-Regulating Exosomal Mir-21/STAT3/β-Catenin Cargo and Preventing Oncogenic Transformation of Normal Gingival Fibroblasts
title Ovatodiolide Suppresses Oral Cancer Malignancy by Down-Regulating Exosomal Mir-21/STAT3/β-Catenin Cargo and Preventing Oncogenic Transformation of Normal Gingival Fibroblasts
title_full Ovatodiolide Suppresses Oral Cancer Malignancy by Down-Regulating Exosomal Mir-21/STAT3/β-Catenin Cargo and Preventing Oncogenic Transformation of Normal Gingival Fibroblasts
title_fullStr Ovatodiolide Suppresses Oral Cancer Malignancy by Down-Regulating Exosomal Mir-21/STAT3/β-Catenin Cargo and Preventing Oncogenic Transformation of Normal Gingival Fibroblasts
title_full_unstemmed Ovatodiolide Suppresses Oral Cancer Malignancy by Down-Regulating Exosomal Mir-21/STAT3/β-Catenin Cargo and Preventing Oncogenic Transformation of Normal Gingival Fibroblasts
title_short Ovatodiolide Suppresses Oral Cancer Malignancy by Down-Regulating Exosomal Mir-21/STAT3/β-Catenin Cargo and Preventing Oncogenic Transformation of Normal Gingival Fibroblasts
title_sort ovatodiolide suppresses oral cancer malignancy by down-regulating exosomal mir-21/stat3/β-catenin cargo and preventing oncogenic transformation of normal gingival fibroblasts
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017298/
https://www.ncbi.nlm.nih.gov/pubmed/31878245
http://dx.doi.org/10.3390/cancers12010056
work_keys_str_mv AT chenjiahong ovatodiolidesuppressesoralcancermalignancybydownregulatingexosomalmir21stat3bcatenincargoandpreventingoncogenictransformationofnormalgingivalfibroblasts
AT wualexanderth ovatodiolidesuppressesoralcancermalignancybydownregulatingexosomalmir21stat3bcatenincargoandpreventingoncogenictransformationofnormalgingivalfibroblasts
AT bamoduoluwaseunadebayo ovatodiolidesuppressesoralcancermalignancybydownregulatingexosomalmir21stat3bcatenincargoandpreventingoncogenictransformationofnormalgingivalfibroblasts
AT yadavvijeshkumar ovatodiolidesuppressesoralcancermalignancybydownregulatingexosomalmir21stat3bcatenincargoandpreventingoncogenictransformationofnormalgingivalfibroblasts
AT chaotsuyi ovatodiolidesuppressesoralcancermalignancybydownregulatingexosomalmir21stat3bcatenincargoandpreventingoncogenictransformationofnormalgingivalfibroblasts
AT tzengyewmin ovatodiolidesuppressesoralcancermalignancybydownregulatingexosomalmir21stat3bcatenincargoandpreventingoncogenictransformationofnormalgingivalfibroblasts
AT mukhopadhyaydebabrata ovatodiolidesuppressesoralcancermalignancybydownregulatingexosomalmir21stat3bcatenincargoandpreventingoncogenictransformationofnormalgingivalfibroblasts
AT hsiaomichael ovatodiolidesuppressesoralcancermalignancybydownregulatingexosomalmir21stat3bcatenincargoandpreventingoncogenictransformationofnormalgingivalfibroblasts
AT leejihchin ovatodiolidesuppressesoralcancermalignancybydownregulatingexosomalmir21stat3bcatenincargoandpreventingoncogenictransformationofnormalgingivalfibroblasts